Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. The company ...

University of North Carolina's Eshelman School of Pharmacy studypublished in the Journal of Oncology Pharmacy Practice Equashield (equashield.com), a leading provider of Closed System Transfer Devices ...

New PP&P State of Pharmacy Compounding report shows EQUASHIELD ® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...

PORT WASHINGTON, N.Y., April 22, 2026 /PRNewswire/ -- In recognition of Earth Day 2026, EQUASHIELD ®, a global leader in hazardous drug handling, today announced its transition to electronic ...

Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...

The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...

EQUASHIELD , a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its remarkable achievement of being named by the Pharmacy ...

Nordic Capital to Advance Achievement of Equashield Strategic Objective of Global Leadership in Hazardous Drug Handling Solutions PORT WASHINGTON, N.Y. , Oct. 7, 2022 /PRNewswire/ -- , a leading ...

"Earth Day is a powerful reminder that sustainability is not a one-day commitment, it's a responsibility that must be embedded into how we operate every day," Matt Stuckert, General Manager. "Our ...

Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced the results of a study conducted by the University of North Carolina's ...